|
Market Closed -
Nasdaq
00:00:00 15/10/2026 +04
|
Pre-market 15:10:47 | |||
| 68.32 USD | +0.15% |
|
65.70 | -3.83% |
| 10-07 | Tempus Enters Multiyear Collaboration With Moderna, Merck Aimed at Commercializing Cancer Drug | DJ |
| 10-07 | Tempus Expands Moderna, Merck Collaboration for Individualized Cancer Therapy | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TEMPUS AI, INC. | Other Biotechnology & Medical Research | +0.15% | -2.89% | +15.70% | -23.98% | - | 12.33B |  |  | |
- Stock Market
- Stocks
- TEM Stock
- Charts Tempus AI, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
